Identifying MTHFD1 and LGALS4 as Potential Therapeutic Targets in Prostate Cancer Through Multi-Omics Mendelian Randomization Analysis
<b>Background:</b> Prostate cancer remains one of the leading causes of cancer-related mortality in men worldwide. The treatment of it is currently based on surgical removal, radiotherapy, and hormone therapy. It is crucial to improve therapeutic prospects for the diagnosis and treatment...
Saved in:
Main Authors: | Huan Han, Hanwen Su, Zhihua Lv, Chengliang Zhu, Jingtao Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/185 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secreted LGALS3BP facilitates distant metastasis of breast cancer
by: Seung-Su Kim, et al.
Published: (2025-01-01) -
Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation
by: Yuanchao Shi, et al.
Published: (2025-02-01) -
Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
by: Ka Zhang, et al.
Published: (2025-02-01) -
Potential drug targets for asthma identified through mendelian randomization analysis
by: Xingxuan Chen, et al.
Published: (2025-01-01) -
Exploring the causal role of plasma metabolites and metabolite ratios in prostate cancer: a two-sample Mendelian randomization study
by: Changzhou Feng, et al.
Published: (2025-01-01)